Vascular endothelial growth factor A (VEGFA) was found as one of the targets of miR-613; in GBM the loss of miR-613 caused increased levels of VEGFA, which, in turn, led to increased angiogenesis [84]. This evidence concerns the gene VEGFA and glioblastoma.